
Can investors control a NY dispensary? Learn how ownership, governance rights, and management agreements affect control, and when OCM approval is required.
OCM does not only look at who owns shares.
They look at who has the ability to influence or direct operations.
Control can include:
If an investor can meaningfully steer the business, OCM may consider them a True Party of Interest (TPI).
These are not the same.
Owning equity or shares in the business.
Having decision-making power over how the business operates.
An investor may:
OCM focuses heavily on governance.
Yes—but only if they truly are.
A passive investor typically:
If those conditions change, they may no longer be passive.
This is where operators get into trouble.
Some investors structure control through:
If those agreements give the investor operational control, OCM may treat them as controlling parties—even if they don’t technically “own” the business.
Labels do not protect you. Substance does.
New York cannabis law was designed to avoid hidden control structures where:
If OCM determines that control exists without disclosure or approval, it may treat that as an unauthorized ownership change.
OCM approval is typically required when:
If you restructure your cap table or governance without filing amendments, you risk regulatory action.
Possible consequences include:
OCM reviews not just initial applications—but ongoing compliance.
Control structures are not a “set it and forget it” issue.
Investor provides $750,000.
In exchange:
That investor likely has governance power requiring disclosure and approval.
Even if the operating agreement says the founder is “CEO.”
In New York:
The license holder must maintain real control.
If OCM believes someone else is running the business behind the scenes, that creates regulatory risk.
Capital is allowed. Hidden control is not.
Review:
Ask one question:
If OCM reviewed this structure, would they say the investor controls the business?
If the answer is unclear, fix it before filing.
Yes, but board authority may trigger governance control and require disclosure.
Possibly. but approval rights are a form of governance and may require regulatory review.
Yes, but revenue participation can increase scrutiny depending on structure.
Attempting to disguise control through side agreements, consulting contracts, or licensing arrangements increases regulatory risk.